+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06566898

Genomic Study of Antimicrobial Resistance in Severe and Mild Pneumonia Patients Using Metagenomics Analyses

Led by Shanghai General Hospital, China · Updated on 2026-04-23

800

Participants Needed

1

Research Sites

24 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying antimicrobial resistance AMR in patients with severe and mild pneumonia by analyzing their microbiomes using metagenomics. The study aims to understand the microbial communities present, the number of resistance genes carried by pathogens, and the genetic diversity of key pathogens from 2019 to 2025. This observational study collects data from multiple hospitals in China to improve pneumonia diagnosis and treatment strategies. Participants diagnosed with severe or mild pneumonia are identified based on established guidelines from the American Thoracic Society, Infectious Diseases Society of America, and British Thoracic Society. Clinical examination samples such as nasopharyngeal or oropharyngeal swabs, sputum, blood, lung tissue, and bronchoalveolar lavage fluid are collected. Advanced sequencing techniques, including next-generation sequencing on the Illumina Novaseq 6000 platform, are used to analyze the microbiome, viruses, bacteria, fungi, and antimicrobial resistance genes. Throughout the study period from 2019 to 2025, researchers analyze microbiome composition, alpha and beta diversity, and the presence of bacterial resistance genes. They use bioinformatics tools to filter and classify sequencing data, identify pathogens, and assess genetic diversity. Outcome measures focus on the microbiomes role in pneumonia, and findings will help characterize resistance patterns. The study runs until September 2026, with continuous recruitment and data collection.

CONDITIONS

Brief Title

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Research Team

M

Mei Kang, MPH

X

Xue Tian, Master

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here